Loading
Latest filing published 18 Sept 2017 for Crescita Therapeutics Inc., €3,407.
No signal scores available.
Yves Bussiere is a declared insider of Crescita Therapeutics Inc., with filings sourced from SEDI. Between 24 May 2017 and 13 September 2017, the trades on record add up to 2 filings.
No open-market sale appears; the market trades are 1 purchase worth €3,407. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The newest entry dates from 18 September 2017: an open-market purchase of €3,407, in Crescita Therapeutics Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations